13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001882053
Total reported value
$427.5M
$427.5M
16 檔
36.3%
At the close of Q3 2025, Boone Capital Management LLC disclosed equity holdings valued at approximately $427.5M, spread across 16 reported holdings.
In Q3 2025, Boone Capital Management LLC displayed an active expansion posture, initiating 12 new positions and adding to 3 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MDT | Medtronic plc | Stock-Healthcare | 13.39% | -10.57% | EXIT | |
| 2 | MIRM | Mirum Pharmaceuticals Inc | Stock-Other | 12.88% | -0.54% | -16.48% | |
| 3 | IONS | Ionis Pharmaceuticals Inc | Stock-Healthcare | 8.96% | -1.87% | — | |
| 4 | CI | THE Cigna Group | Stock-Healthcare | 7.84% | -0.97% | +133.07% | |
| 5 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 7.84% | +0.71% | — | |
| 6 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 7.66% | — | -7.72% | |
| 7 | RAPT | Rapt Therapeutics Inc | Stock-Other | 6.62% | — | — | |
| 8 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 6.58% | +2.05% | — | |
| 9 | BMRN | Biomarin Pharmaceutical Inc | Stock-Healthcare | 5.83% | -1.67% | -26.57% | |
| 10 | ICLR | ICON Public Limited Company | Stock-Healthcare | 5.50% | — | — | |
| 11 | COGT | Cogent Biosciences Inc | Stock-Other | 4.45% | — | — | |
| 12 | KOD | Kodiak Sciences Inc | Stock-Other | 3.84% | +0.15% | — | |
| 13 | LIVN | LivaNova PLC | Stock-Other | 2.88% | — | — | |
| 14 | QURE | uniQure N.V. | Stock-Other | 2.82% | — | — | |
| 15 | CLPT | Clearpoint Neuro Inc | Stock-Other | 2.03% | — | — | |
| 16 | ABEO | Abeona Therapeutics Inc | Stock-Other | 0.87% | — | -59.92% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | MIRM | Mirum Pharmaceuticals Inc | +3.6% | -16.48% | Trim |
| 2 | MDT | Medtronic plc | +1.4% | — | Add |
| 3 | CI | THE Cigna Group | -0.1% | +133.07% | Add |
| 4 | BMRN | Biomarin Pharmaceutical Inc | -2% | -26.57% | Add |
| 5 | UNM | Unum Group | — | EXIT | Sold out |
| 6 | IONS | Ionis Pharmaceuticals Inc | — | NEW | New buy |
| 7 | GMED | Globus Medical Inc - A | — | EXIT | Sold out |
| 8 | BBIO | Bridgebio Pharma Inc | — | NEW | New buy |
| 9 | NBIX | Neurocrine Biosciences Inc | — | NEW | New buy |
| 10 | MOH | Molina Healthcare Inc | — | EXIT | Sold out |
| 11 | RAPT | Rapt Therapeutics Inc | — | NEW | New buy |
| 12 | UNH | Unitedhealth Group Inc | — | NEW | New buy |
| 13 | PRGO | Perrigo Company plc | — | EXIT | Sold out |
| 14 | ISRG | Intuitive Surgical Inc | — | EXIT | Sold out |
| 15 | PNTG | Pennant Group Inc/the | — | EXIT | Sold out |
| 16 | ICLR | ICON Public Limited Company | — | NEW | New buy |
| 17 | OFIX | Orthofix Medical Inc | — | EXIT | Sold out |
| 18 | COGT | Cogent Biosciences Inc | — | NEW | New buy |
| 19 | KOD | Kodiak Sciences Inc | — | NEW | New buy |
| 20 | LIVN | LivaNova PLC | — | NEW | New buy |
| 21 | QURE | uniQure N.V. | — | NEW | New buy |
| 22 | BHVN | Biohaven Ltd. | — | EXIT | Sold out |
| 23 | CLPT | Clearpoint Neuro Inc | — | NEW | New buy |
| 24 | ABEO | Abeona Therapeutics Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Boone Capital Management LLC reported a total U.S. public equity portfolio value of $427.5M across 16 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including MDT, MIRM, IONS) accounted for 36.3% of total reported equity market value during Q3 2025.
Top New Position Initiated
IONS
市值: $27.3M
Top Position Liquidated / Trimmed
UNM
前期市值: $57.1M
During Q3 2025, Boone Capital Management LLC's top holdings by market value included MDT (13.4%)、MIRM (12.9%)、IONS (9.0%). The largest single position, MDT, represented 13.4% of total portfolio value.
In Q3 2025, Boone Capital Management LLC made 24 total portfolio adjustments, initiating 12 new buys, adding to 3 positions, trimming 1 holdings, and fully liquidating 8 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.